Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20345476rdf:typepubmed:Citationlld:pubmed
pubmed-article:20345476lifeskim:mentionsumls-concept:C0280325lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C1424222lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C1514475lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:20345476lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:20345476pubmed:issue5lld:pubmed
pubmed-article:20345476pubmed:dateCreated2010-6-10lld:pubmed
pubmed-article:20345476pubmed:abstractTextDJ-1 is frequently overexpressed in a large variety of solid tumors, but the DJ-1 expression in laryngeal squamous cell cancer and its clinical/prognostic significance is unclear. We aimed to evaluate DJ-1 protein expression in glottic squamous cell carcinoma (GSCC) and to correlate this with clinicopathological data including patient survival. The expression of DJ-1 in GSCCs (60) and adjacent normal tissue (44) was assessed by immunohistochemistry and western blot analysis. In addition, the role of DJ-1 was investigated in tumorigenesis by transfecting DJ1-specific siRNA into laryngeal squamous cell carcinoma (LSCC) Hep-2 cells. Our data showed that positive expression of DJ-1 was found in 85% of GSCCs. In univariate survival analysis of the GSCC cohorts, a highly significant association between DJ-1 expression with shortened patient overall survival (5-year survival rate 92.9%vs 66.6%; P = 0.001; log rank test) was demonstrated. In multivariate analyses, DJ-1, tumor grading, and pT status were significant prognostic parameters for shortened patient overall survival. Furthermore, siRNA targeting DJ-1 can effectively inhibit DJ-1 expression, resulting in enhanced apoptosis and less proliferation of Hep-2 cells. We concluded that DJ-1 overexpression might be a novel independent molecular marker for poor prognosis (shortened overall survival) of patients with GSCC.lld:pubmed
pubmed-article:20345476pubmed:languageenglld:pubmed
pubmed-article:20345476pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20345476pubmed:citationSubsetIMlld:pubmed
pubmed-article:20345476pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20345476pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20345476pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20345476pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20345476pubmed:statusMEDLINElld:pubmed
pubmed-article:20345476pubmed:monthMaylld:pubmed
pubmed-article:20345476pubmed:issn1349-7006lld:pubmed
pubmed-article:20345476pubmed:authorpubmed-author:WangZhang-Fen...lld:pubmed
pubmed-article:20345476pubmed:authorpubmed-author:JiangHong-Yan...lld:pubmed
pubmed-article:20345476pubmed:authorpubmed-author:LeiWen-BinWBlld:pubmed
pubmed-article:20345476pubmed:authorpubmed-author:ZhuangHui-Wen...lld:pubmed
pubmed-article:20345476pubmed:authorpubmed-author:WenWei-PingWPlld:pubmed
pubmed-article:20345476pubmed:authorpubmed-author:ZhuXiao-LinXLlld:pubmed
pubmed-article:20345476pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20345476pubmed:volume101lld:pubmed
pubmed-article:20345476pubmed:ownerNLMlld:pubmed
pubmed-article:20345476pubmed:authorsCompleteYlld:pubmed
pubmed-article:20345476pubmed:pagination1320-5lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:meshHeadingpubmed-meshheading:20345476...lld:pubmed
pubmed-article:20345476pubmed:year2010lld:pubmed
pubmed-article:20345476pubmed:articleTitleDJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma.lld:pubmed
pubmed-article:20345476pubmed:affiliationDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital, Guangzhou, China.lld:pubmed
pubmed-article:20345476pubmed:publicationTypeJournal Articlelld:pubmed